Cormorant Asset Management, LP Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$2.3B
Holdings
57
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (57 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | $426.7T | 18716100.25% | |
| 2 | EYPTEYEPOINT PHARMACEUTICALS INC | 6,893,235 | $142.5T | 6250226.66% | |
| 3 | ACLXARCELLX INC | 1,780,000 | $123.8T | 5430619.11% | |
| 4 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,700,000 | $107.0T | 4694935.36% | |
| 5 | BBIOBRIDGEBIO PHARMA INC | 3,203,029 | $99.0T | 4344427.60% | |
| 6 | PRAXPRAXIS PRECISION MEDICINES I | 1,310,000 | $79.9T | 3506515.04% | |
| 7 | CRBPCORBUS PHARMACEUTICALS HLDGS | 2,025,000 | $79.5T | 3485669.72% | |
| 8 | TARSTARSUS PHARMACEUTICALS INC | 2,139,102 | $77.8T | 3410893.17% | |
| 9 | —LONGBOARD PHARMACEUTICALS IN | 3,353,141 | $72.4T | 3177150.42% | |
| 10 | EWTXEDGEWISE THERAPEUTICS INC | 3,006,534 | $54.8T | 2405598.58% | |
| 11 | CRNXCRINETICS PHARMACEUTICALS IN | 1,150,000 | $53.8T | 2361395.27% | |
| 12 | BMEABIOMEA FUSION INC | 3,570,872 | $53.4T | 2341788.56% | |
| 13 | KRROKORRO BIO INC | 529,170 | $47.6T | 2089151.48% | |
| 14 | PCVXVAXCYTE INC | 685,000 | $46.8T | 2052612.95% | |
| 15 | AUTLAUTOLUS THERAPEUTICS PLC | 6,616,667 | $42.2T | 1851791.81% | |
| 16 | PHVSPHARVARIS N V | 1,711,460 | $39.6T | 1734997.73% | |
| 17 | NAMSNEWAMSTERDAM PHARMA COMPANY | 1,500,000 | $35.5T | 1556161.30% | |
| 18 | CGONCG ONCOLOGY INC | 800,000 | $35.1T | 1540588.72% | |
| 19 | ALXOALX ONCOLOGY HLDGS INC | 3,142,079 | $35.0T | 1536824.15% | |
| 20 | BHVNBIOHAVEN LTD | 616,963 | $33.7T | 1480127.90% | |
| 21 | MRUSMERUS N V | 715,000 | $32.2T | 1412343.05% | |
| 22 | AVTEAEROVATE THERAPEUTICS INC | 1,069,796 | $31.6T | 1387664.59% | |
| 23 | ABVXABIVAX SA | 2,130,000 | $30.5T | 1336127.33% | |
| 24 | HLXCHELIX ACQUISITION CORP II | 2,909,000 | $30.3T | 1327117.17% | |
| 25 | MRNS*MARINUS PHARMACEUTICALS INC | 3,250,000 | $29.4T | 1288795.46% | |
| 26 | TRMLTOURMALINE BIO INC | 1,250,000 | $28.6T | 1255676.31% | |
| 27 | JANXJANUX THERAPEUTICS INC | 750,000 | $28.2T | 1238678.08% | |
| 28 | NGNENEUROGENE INC | 538,714 | $27.4T | 1202841.10% | |
| 29 | CRGXCARGO THERAPEUTICS INC | 1,182,563 | $26.4T | 1157845.68% | |
| 30 | RYTMRHYTHM PHARMACEUTICALS INC | 550,000 | $23.8T | 1045402.62% | |
| 31 | APLSAPELLIS PHARMACEUTICALS INC | 400,000 | $23.5T | 1031387.30% | |
| 32 | ARQTARCUTIS BIOTHERAPEUTICS INC | 2,125,000 | $21.1T | 923772.00% | |
| 33 | IDYAIDEAYA BIOSCIENCES INC | 450,000 | $19.7T | 866186.36% | |
| 34 | CABACABALETTA BIO INC | 1,100,000 | $18.8T | 823197.27% | |
| 35 | CATBUSDASTRIA THERAPEUTICS INC | 1,300,000 | $18.3T | 802645.85% | |
| 36 | ENGNENGENE HOLDINGS INC | 1,000,000 | $16.9T | 743535.84% | |
| 37 | IM8NINSMED INC | 575,000 | $15.6T | 684305.21% | |
| 38 | VTYXVENTYX BIOSCIENCES INC | 2,710,000 | $14.9T | 653829.01% | |
| 39 | NKTXNKARTA INC | 1,350,000 | $14.6T | 640164.62% | |
| 40 | SLNSILENCE THERAPEUTICS PLC | 625,000 | $13.5T | 592196.69% | |
| 41 | —MERSANA THERAPEUTICS INC | 2,600,000 | $11.6T | 510956.08% | |
| 42 | CMPXCOMPASS THERAPEUTICS INC | 5,560,300 | $11.0T | 482942.72% | |
| 43 | KYTXKYVERNA THERAPEUTICS INC | 440,000 | $10.9T | 479442.44% | |
| 44 | BEAMBEAM THERAPEUTICS INC | 300,000 | $9.9T | 434803.97% | Put |
| 45 | IMRXIMMUNEERING CORP | 3,295,273 | $9.5T | 417754.80% | |
| 46 | SYRESPYRE THERAPEUTICS INC | 250,000 | $9.5T | 415963.34% | |
| 47 | AVBPARRIVENT BIOPHARMA INC | 515,000 | $9.2T | 403478.96% | |
| 48 | RCKTROCKET PHARMACEUTICALS INC | 300,000 | $8.1T | 354528.42% | |
| 49 | IRONDISC MEDICINE INC | 125,000 | $7.8T | 341390.43% | |
| 50 | CNTACENTESSA PHARMACEUTICALS PLC | 561,600 | $6.3T | 278379.82% | |
| 51 | GHRSGH RESEARCH PLC | 593,043 | $6.3T | 277316.41% | |
| 52 | STOKSTOKE THERAPEUTICS INC | 427,163 | $5.8T | 252964.54% | |
| 53 | LNTHLANTHEUS HLDGS INC | 75,000 | $4.7T | 204768.46% | |
| 54 | VERVVERVE THERAPEUTICS INC | 350,000 | $4.6T | 203891.13% | |
| 55 | RAPTEURRAPT THERAPEUTICS INC | 496,750 | $4.5T | 195679.99% | |
| 56 | VYNEVYNE THERAPEUTICS INC | 1,394,336 | $4.3T | 187775.13% | |
| 57 | BCABBIOATLA INC | 1,170,870 | $4.0T | 176684.87% |